Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18
Closed -$1.21K 496
2025
Q3
$1.21K Buy
+18
New +$1.42K ﹤0.01% 491
2025
Q1
Sell
-220
Closed -$17.1K 448
2024
Q4
$17.1K Hold
220
﹤0.01% 296
2024
Q3
$14.7K Hold
220
﹤0.01% 276
2024
Q2
$24.9K Hold
220
﹤0.01% 253
2024
Q1
$30.5K Hold
220
﹤0.01% 245
2023
Q4
$27.3K Hold
220
﹤0.01% 247
2023
Q3
$20.5K Hold
220
﹤0.01% 232
2023
Q2
$28.3K Hold
220
﹤0.01% 235
2023
Q1
$25.6K Buy
+220
New +$24.6K ﹤0.01% 230

Other funds holding DXCM

Avalon Trust's DXCM Position: Q4 2025 in Review

Avalon Trust sold out of DexCom (DXCM) in Q4 2025, closing a stake of 18 shares — an estimated $1.21K sold.

Avalon Trust first reported a position in DXCM in Q1 2023 and held it in 9 quarters. The position peaked at $30.5K in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Avalon Trust reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Avalon Trust sold 18 DexCom shares in Q4 2025, an estimated $1.21K.
  • Avalon Trust first reported a position in DexCom in Q1 2023 and held it in 9 quarters.
  • Avalon Trust's DexCom position peaked at $30.5K in Q1 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.